Nabriva Therapeutics PLC Sustainability Reports
Nabriva Therapeutics PLC is a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections. Its portfolio has historically featured antibiotic treatments such as Xenleta and Sivextro.
Sector: Manufacturing
Country: Ireland
Exchange: OTC Markets
LEI: 529900R7DZDU655YTV33
FIGI: BBG00GGS47F9
2 reports from 2017 to 2019
